In this study, we found that injecting miR-659-3p in vivo reduced N-cadherin expression and increased E-cadherin expression in the mouse osteosarcoma model, which indicated that miR-659-3p inhibited EMT of osteosarcoma cells. The gene discussed is CDH2; the disease is osteosarcoma.